54 min listen
Ep30: Orilissa and Lupron. Part 1 – Misconceptions and Marketing
Ep30: Orilissa and Lupron. Part 1 – Misconceptions and Marketing
ratings:
Length:
86 minutes
Released:
Feb 6, 2020
Format:
Podcast episode
Description
Why are doctors so misinformed about endo treatment, and the benefits, risks, and limitations of GnRh drugs like Orilissa and Lupron? We talk about how drug companies are influencing both the doctor and the patient through marketing tactics, “awareness” campaigns, underwriting medical education credits for doctors, and more. We also talk about the lack of transparency around these tactics, how this misinformation affects our standard of care, and the quick facts around Orilissa and Lupron. Plus, Amy tells her story of being in a near menopausal state! CONNECT WITH US! INSTAGRAM: @in16yearsofendo WEBSITE AND RESOURCES: insixteenyears.com
Sources at: insixteenyears.com/lupron
insixteenyears.com/orilissa
Sources at: insixteenyears.com/lupron
insixteenyears.com/orilissa
Released:
Feb 6, 2020
Format:
Podcast episode
Titles in the series (100)
Ep2: From Dismissal to Diagnosis: Ever been dismissed by a doctor – or several – and start to doubt yourself? We talk about the obstacles we face trying to get diagnosed with endo and how lonely it can feel when no one believes your symptoms. We talk about Amy's journey to diagnosis, by In Sixteen Years of Endometriosis